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Condylomas are caused by human papillomavirus (HPV), but may in rare cases be ‘‘negative for HPV’’ by
PCR. Metagenomic sequencing can be used for an unbiased assessment of the presence of virus. Ten
swab sample pools, each containing four cases of ‘‘HPV-negative’’ condylomas, were subjected to
metagenomic sequencing. One pool contained Molluscum contagiosum. Five pools contained HPV, of
which three pools contained novel putative HPV-types. The 12 samples in these three pools were
sequenced individually. Six of these contained HPV and two contained Molluscum contagiosum.
Altogether, 1337 HPV-related reads were detected, representing 23 novel putative Gammapapilloma-
viruses, 10 established HPV types (genital HPV types 6, 57, 58 and 66, Betapapillomavirus types 5, 105,
124, and Gammapapillomavirus types 50, 130, 150) and two described HPV sequences (KC7 and FA69).
Complete genomes of Gammapillomavirus FA69 and SE87 were compiled. Metagenomic sequencing
reveals that seemingly ‘‘HPV-negative’’ condylomas contain known and previously unknown HPV types.
& 2013 Elsevier Inc. All rights reserved.Introduction
Condylomas are a very common sexually-transmitted disease
caused by infection by human papillomavirus (HPV), most com-
monly by HPV 6 of the Alphapapillomavirus genus (Gissmann et al.,
1982; Bernard et al., 2010). The HPVs are a large group of small,
non-enveloped dsDNA-viruses that infect keratinocytes of the skin
and mucosa. There are 156 established HPV types (Bernard et al.,
2010; Bottalico et al., 2011; Chouhy et al., 2010; de Villiers et al.,
2004; Kohler et al., 2011; Kovanda et al., 2011) and several complete
genomes representing putative HPV types (Foulongne et al., 2012;
Li et al., 2012). In addition to the established types, a large number of
subgenomic HPV sequences representing novel putative HPV types,
have been discovered using the broad general primer PCR system FAP
(FA-isolates) (Forslund, 2007), CUT PCR (GC-isolates) (Chouhy et al.,
2010) and/or using sequencing (SE-isolates) (Ekstrom et al., 2011).
The oncogenic HPV types are the main cause of cervical cancer,
being found in close to 100% of cervical tumors (Walboomers et al.,
1999). These HPV types also cause other types of malign mucosal
tumors, such as anal, vulvar, and oral cancers (IARC, 2012). A few
HPV negative cervical cancers exist, and four possible explanations
(in addition to true negativity) have been suggested (Walboomers
and Meijer, 1997): (i) specimen inadequacy, (ii) loss of the L1 genell rights reserved.
nd).due to integration, (iii) detection method insensitivity, and (iiii) the
existence of still unidentiﬁed HPV types that are not detectable by
the method. We have previously pointed out that extended analysis
of HPV-associated clinical lesions, such as cervical cancer or con-
dylomas, that are seemingly ‘‘HPV-negative’’ is a promising strategy
to discover new, pathogenic HPVs (Ekstrom et al., 2010). In southern
Sweden, a systematic condyloma reporting system has performed
HPV genotyping of the largest series of condylomas reported to date
in the literature (Sturega˚rd et al., 2013). This has enabled collection
of a sizable number of condyloma samples that are seemingly
negative by broad HPV-primer PCR system (Soderlund-Strand
et al., 2009). High-throughput sequencing has, for many years, been
instrumental in the characterization of bacterial metagenomes and
the discovery of new viruses (Didelot et al., 2012; Human
Microbiome Project, 2012; Mokili et al., 2012; Willner et al., 2012),
and has, in recent years, also been used for virus detection in skin
samples (Ekstrom et al., 2011; Foulongne et al., 2012).
In the present study, we used metagenomic sequencing of
‘‘HPV-negative’’ condylomas in order to obtain a comprehensive
map of which known or previously unknown viruses are present
in these lesions.Results
Forty samples of apparently HPV-negative condylomas were
pooled in ten pools with four samples in each. The samples were
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using 454 technology. In three of the pools, putative novel HPV-
types were detected and the twelve samples that had been
included in these pools were also sequenced individually.
In total, we obtained 104,740 sequence reads. These were 43%
bacterial sequences (45,018 reads), 28% human sequences (29,062
reads), 4% viral sequences (4269 reads), 0.3% phage sequences
(292 reads), 9% other sequences (9568 reads), and 16% unknown
sequences (16,531 reads). As ‘‘other’’, we have classiﬁed reads
with similarities to other sequences present in GenBank (e.g.,
plants, plant viruses, synthetic constructs, or non-human viruses).
Sequences which were not similar to any sequence deposited in
GenBank were classiﬁed as ‘‘unknown’’.
Among the viral reads, 52% (2207/4269) were related to viruses
known to infect humans, and were retained for further analysis.
Since swab samples do not contain enough DNA for 454 sequen-
cing, we used whole genome ampliﬁcation (WGA) to increase theTable 1
Schematic overview of sequenced samples. Pooled samples (four samples in each pool)
samples to the right. Only samples from three pools (pool 3, 5, and 10) were sequence
First seq Virus type Reads Fragments/
contigs
Mean length
(bp)
Second seq
Pool 1 HPV6 24 5 1564 (391–4098)
HPV66 1 1 295
Pool 2 Molluscum
contagiosum
virus subtype 1
12 12 222 (89–469)
Pool 3 HPV57 2 2 139 (105–173) Sample 1
SE92 2 1 311 Sample 2
SE95 1 1 691 Sample 3
SE96 1 1 109
Sample 4
Pool 4 – – – –
Pool 5 FA69 40 13 329 (91–800) Sample 5
SE92 2 1 311 Sample 6
SE93 1 1 173 Sample 7
SE94 3 1 240
SE95 8 1 1047
SE96 3 1 109
SE97 1 1 189 Sample 8
SE98 1 1 145
SE99 1 1 148
SE100 1 1 418
Pool 6 – – – –
Pool 7 HPV6 177 7 819 (391–1347)
HPV124 1 1 264
Pool 8 – – – –
Pool 9 – – – –
Pool 10 SE102 1 1 382 Sample 9
SE103 1 1 338
SE106 1 1 375
Sample 10
Sample 11
Sample 12
a Previously published (Ekstrom et al., 2011).amount of DNA prior to the high throughput sequencing. WGA can
introduce errors such as chimeras or genome rearrangements
(Lasken and Stockwell, 2007). Therefore, the reads were processed
with stringent default settings to remove chimeras using both an
automatic process and CodonCode Aligner (version 4.0.3, Codon-
Code Corporation), with the result that only 63% (1385/2207) of
the sequences related to human viruses remained. Among these
sequences, 96.5% (1337/1385) were related to HPV and 3.5%
(48/1385) were Molluscum contagiosum sequences (Table 1).
Among the 1 337 HPV-related reads, 11% (145/1337) belonged to
subgenomic fragments of novel putative HPV types (Tables 1 and
2). Most of the HPV-related reads, (1064 reads) were detected in
the individually sequenced samples (Table 1).
Five out of ten pools were HPV-positive, out of which two
contained sequences from HPV6 and three contained sequences
from novel putative HPV types (Table 1). In four of the pools, no
viral reads were detected. Sequencing of the individual samplesfrom the ﬁrst sequencing round are seen to the left and the corresponding single
d as single samples.
Sex (age) Virus type Reads Fragments/
contigs
Mean length
(bp)
F (41) Molluscum
contagiosum
virus subtype 1
3 3 NA
F (28) – – – –
M (41) HPV57 2 2 492.5 (489–496)
HPV150 1 1 484
SE95 1 1 401
M (40) Molluscum
contagiosum
virus subtype 1
33 25 465 (414–520)
F (38) – – – –
F (33) SE101 3 1 504
M (30) HPV6 25 6 625 (144–2143)
HPV isolate
FA69
858 1 Complete
HPV isolate
KC7
24 4 1029 (473–1415)
SE87 80 1 Complete
M (24) SE8a 8 1 629
SE104 1 1 506
SE105 1 1 501
SE109 25 1 2302
SE110 1 1 531
SE113 1 1 507
SE114 2 1 330
F (26) HPV6 3 1 2143
HPV50 3 2 686 (497–876)
HPV58 15 9 385 (218–488)
F (25) HPV5 1 1 485
HPV105 5 3 487 (474–496)
HPV130 2 2 345 (247–443)
SE107 1 1 476
SE116 1 1 458
M (28) – – – –
F (25) – – – –
Table 2
Summary of detected putative novel HPV types. An SE-number was assigned to each novel HPV-related sequence/contig, if less than 90% similar to the closest complete
genome of HPV (all belonging to the gamma genus). SE-numbers 88–91 were detected in other projects. SE-numbers 108, 111, 112, and 115 were later identiﬁed as human
papillomavirus isolate KC7 (GenBank JX444072.1). SE-numbers 93, and 96–99 were too short for GenBank deposition, and can be obtained from the corresponding author.
SE-
number
GenBank accession
number
Closest complete HPV-genome.
BLAST with highest coverage
Length Identity Coverage Start End Nr of
reads
Location in
genome
Source
SE87 KC108721 Human papillomavirus isolate
915F 06 005 FS1
7225 85 99 103 100 80 Complete Sample 7
SE92 KC108723 HPV48 311 80 99 1559 1868 4 E1 Pool 3 and 5
SE93 -a HPV48 173 86 99 1036 1207 1 E1 Pool 5
SE94 KC108724 HPV48 240 83 100 2081 2320 3 E1 Pool 5
SE95 KC108725 HPV48 1047 81 95 3217 4204 10 E2-L2 Pool 3, pool 5, and
sample 3
SE96 -a HPV48 109 78 81 4817 4905 4 L2 Pool 3 and 5
SE97 -a HPV48 189 82 100 5399 5586 1 L1 Pool 5
SE98 -a HPV48 145 77 100 6278 6422 1 L1 Pool 5
SE99 -a HPV48 148 80 93 6734 6867 1 L1-URR Pool 5
SE100 KC108726 HPV48 418 90 94 7054 364 1 URR-E6 Pool 5
SE101 KC108727 HPV88 504 62 97 4642 5140 3 L2 Sample 6
SE102 KC108728 HPV112 382 75 96 6495 6862 1 L1 Pool 10
SE103 KC108729 HPV147 346 76 98 2672 3013 1 E2 Pool 10
SE104 KC108730 HPV127 506 73 94 6342 6815 1 L1 Sample 8
SE105 KC108731 Human papillomavirus isolate KC7 501 76 94 4867 5346 1 L2-L1 Sample 8
SE106 KC108732 HPV137 378 70 96 1331 1699 1 E1 Pool 10
SE107 KC108733 HPV144 476 67 99 6288 6766 1 L1-URR Sample 10
SE109 KC108734 Human papillomavirus isolate
915F 06 008 CG1
2302 71 99 2515 4813 25 E1-L2 Sample 8
SE110 KC108735 Human papillomavirus isolate
915F 06 008 CG2
531 72 96 3122 3645 1 E2 Sample 8
SE113 KC108736 Human papillomavirus isolate
915F 06 008 CG3
507 74 99 988 1468 1 E1 Sample 8
SE114 KC108737 Human papillomavirus isolate KC7 330 82 100 2149 2478 2 E1 Sample 8
SE116 KC108738 Human papillomavirus isolate
915F 06 002 KN2
458 66 98 260 713 1 E6-E7 Sample 10
a Too short sequence for deposition in GenBank.
Table 3
Similarity between the complete genome of SE87 and other representative HPVs. HPV isolate 915F 06 005 FS1 is the most similar type.
SE87 Alpha Beta Gamma1 Gamma-2 Gamma-3 Gamma-4 Gamma-5 Gamma-6 Gamma-7 Gamma-8 Gamma-9 Gamma-10 Gamma-x
HPV 16 HPV 38 HPV 4 HPV 150 HPV 48 HPV 60 HPV 88 HPV 101c HPV 109 HPV 112 HPV 116 HPV 121 HPV isolate
915F 06 005 FS1
E6 aaa 27.0 27.0 43.6 31.6 46.5 47.1 49.3 – 37.3 41.7 40.1 42.9 75.5
E6 ntb 48.0 51.0 55.7 47.2 58.2 57.7 58.6 – 54.6 58.1 55.5 53.7 78.5
E7 aa 28.6 34.6 41.0 39.0 55.2 57.3 51.0 38.8 37.4 57.7 54.1 49.0 87.6
E7 nt 46.8 48.5 53.0 46.4 56.0 61.5 57.1 50.3 49.7 58.8 56.8 54.2 84.9
E1 aa 10.1 44.3 53.3 42.3 48.0 56.6 56.1 41.3 48.7 49.2 49.8 48.9 80.4
E1 nt 55.0 57.7 62.2 56.6 60.4 64.1 64.1 57.2 59.7 60.9 61.3 61.6 78.8
E2 aa 28.4 37.6 43.6 32.3 44.3 51.0 45.6 38.1 41.7 45.5 43.8 41.2 80.2
E2 nt 48.2 50.7 55.9 49.8 57.8 60.8 58.4 53.3 56.8 57.6 57.2 55.1 80.9
E4 aa 16.3 16.6 38.5 16.7 37.9 40.5 35.1 26.6 32.5 34.1 25.2 34.6 74.7
E4 nt 41.4 43.7 55.8 42.0 55.6 59.4 56.5 53.4 57.6 52.5 53.8 54.0 84.5
L2 aa 27.6 31.8 39.7 32.9 31.3 42.8 40.1 34.6 38.5 40.7 35.4 41.4 66.7
L2 nt 46.0 46.8 53.3 48.1 49.8 55.5 51.5 50.0 52.1 54.7 50.6 53.6 69.7
L1 aa 46.7 53.3 55.9 52.8 54.6 64.1 58.1 50.3 51.4 54.9 54.1 53.8 86.4
L1 nt 57.3 59.7 61.9 59.1 61.8 66.5 62.3 57.4 59.2 61.7 60.2 61.3 79.4
a aa¼amino acid.
b nt¼nucleotide.
c HPV 101 (and HPV 103) from the Gamma-6 species lacks the E6 ORF (Chen et al., 2007).
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samples (Table 1). Four samples contained no viral reads
(Table 1).
Altogether, we identiﬁed singletons and contigs with lengths
ranging from 89 bp up to 7356 bp. The genital HPV-types 6, 57, 58,
and 66, the Betapapillomavirus types 5, 105, 124, and the Gam-
mapapillomavirus types 50, 130, 150, and isolate KC7 (GenBank
accession number JX444072.1) were detected. Two previously
described subgenomic fragments of putative HPV types FA69(FA69 fragment, GenBank accession number AY049760.1), and
SE8 (GenBank accession number JQ250773.1) were also identiﬁed.
In addition, 23 subgenomic fragments from novel putative
types were detected; SE87, SE92-SE107, SE109, SE110, SE113,
SE114, and SE116 (Table 2). Their closest related established HPV-
types, with the highest coverage in BLAST, were all from the
Gammapapillomavirus genus. The nine fragments SE92-100 may
belong to the same novel putative type as these are non-
overlapping sequences that were all related to HPV48 (with
Table 4
Similarity between the complete genome of FA69 and other representative HPVs.
FA69 Alpha Beta Gamma-1 Gamma-2 Gamma-3 Gamma-4 Gamma-5 Gamma-6 Gamma-7 Gamma-8 Gamma-9 Gamma-10 Gamma-x
HPV 16 HPV 38 HPV 4 HPV 150 HPV 48 HPV 60 HPV 88 HPV 101c HPV 109 HPV 112 HPV 116 HPV 121 HPV 133
E6 aaa 24.5 33.3 42.6 31.7 38.5 45.8 42.3 – 31.5 39.4 39.6 77.6 67.8
E6 ntb 44.7 50.9 54.5 51.4 52.0 56.4 53.1 – 49.5 55.3 57.0 80.2 68.8
E7 aa 28.0 39.8 42.6 38.7 48.0 41.8 46.9 37.8 35.7 40.8 53.5 91.8 72.7
E7 nt 44.3 50.3 53.1 53.1 55.3 54.8 58.8 51.5 53.5 51.2 58.6 92.9 78.8
E1 aa 12.7 49.5 55.4 45.3 44.7 52.8 56.1 46.3 51.0 49.8 50.6 90.8 72.8
E1 nt 56.8 61.1 65.7 60.4 61.3 65.6 63.7 60.3 59.7 63.3 63.0 87.6 78.0
E2 aa 29.8 40.2 40.3 35.2 43.9 44.3 44.2 45.5 48.3 43.2 39.9 88.5 67.4
E2 nt 51.2 52.3 56.9 51.5 57.6 57.0 60.2 58.4 60.2 58.6 55.1 87.2 75.4
E4 aa 17.2 20.9 41.6 17.9 37.6 32.1 40.5 36.3 39.6 37.0 33.3 77.0 61.7
E4 nt 44.9 48.6 54.6 47.7 57.2 52.0 58.6 54.1 54.3 54.9 51.5 84.4 69.3
L2 aa 26.4 39.5 52.8 41.5 39.5 45.6 43.3 44.7 50.7 41.2 42.1 90.6 80.9
L2 nt 47.1 51.2 59.0 52.0 51.9 57.0 54.9 53.3 58.9 54.6 54.2 81.8 75.7
L1 aa 48.4 54.7 60.8 54.8 55.7 56.5 57.9 56.7 59.6 58.3 55.0 89.0 83.4
L1 nt 58.2 60.2 65.3 62.6 61.8 62.8 62.1 60.9 65.0 62.7 61.6 81.6 78.2
a aa¼amino acid.
b nt¼nucleotide.
c HPV 101 (and HPV 103) from the Gamma-6 species lacks the E6 ORF (Chen et al., 2007).
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with similar identity to the closest HPV type/HPV-isolate actually
belong to the same virus, the 23 subgenomic fragments detected
would represent 13 novel putative HPV types (Table 2). Some
sequences detected during the course of our study that were
initially assigned SE-numbers (SE108, 111, 112, and 115) have
been deleted, since they were found to belong to the recently
described HPV-isolate KC7. The SE93 as well as the SE96-99
sequences were too short to be accepted for GenBank deposition.
For 61% (14/23) of the subgenomic novel putative types, we
only detected a single sequence of each (Table 2), ranging from
145 to 507 bp (mean 368 bp). For the other novel putative types,
we detected 2 to 80 reads of each (mean 15 reads) (Table 2).
For one of the novel putative HPV types, SE87 (GenBank
KC108721), we obtained the complete genome comprising a
7226 bp long contig assembled by 80 reads from one single sample
(sample 7, the same sample from which the complete genome of
FA69 was also obtained (Table 2)). SE87 is most closely related (80%
identity in the L1 ORF) to HPV isolate 915F 06 005 FS1 (GenBank
JF966373.1), of the Gammapapillomavirus genus (Table 3).
The complete genome of HPV isolate FA69 (GenBank KC108722)
was assembled from 858 reads in one sample (sample 7) (Table 4).
Forty reads of FA69 were also detected in the pool that contained
sample 7 (Table 1). Initially, the ORFs were incomplete in three and
four positions of the contigs for SE87 and FA69, respectively. In order
to explore whether the incomplete ORFs may have been attributable
to sequencing errors, we performed type-speciﬁc PCRs from the
original sample and the sequences of the PCR amplimers were used
to edit the ﬁnal sequence. The errors detected were deletions of
thymine in T-homopolymers, but also false insertion of a cytosine
was found. The error rate of 454-sequencing is reported to be more
frequent in homopolymers of greater lengths (Luo et al., 2012).Discussion
The metagenomic approach has emerged as a cost-effective
technique for virus discovery, clinical microbiology, and public
health (Mokili et al., 2012). We used the 454 high-throughput
sequencing approach to explore the viruses present in ‘‘HPV-
negative’’ condylomas, and demonstrated that a large proportion
of ‘‘HPV-negative’’ condylomas do contain viral sequences of
which the vast majority are related to HPV (96.5%). Although
our study comprised samples from only 40 patients, sequencesfrom 12 different HPV types or putative types were found. In
addition, 23 previously unknown subgenomic sequences from at
least 13 different putative HPV types were found. This suggests
that the initial ‘‘HPV-negativity’’ may be partially explained by
the presence of distantly related HPV types that may be difﬁcult
to detect using PCR systems based on known HPV sequences. The
detection of Molluscum contagiosum virus in at least three
samples suggests that the clinical diagnosis of condyloma was
incorrect and that the reason why these three condylomas were
‘‘HPV-negative’’ was that they were not condylomas but mollusca.
The clinical distinction between condylomas and mollusca is not
always straightforward. Indeed, a recent study reported conco-
mitant condylomas and mollusca among 11% of patients with
viral infections on the pubis (Castronovo et al., 2012).
HPV6 is the most common cause of condylomas (Gissmann
et al., 1982) and was detected in at least four of the samples. In
addition, we detected HPV58 and HPV66, which have previously
been detected among condylomas with prevalences of about 2%
and 6%, respectively (Aubin et al., 2008; Sturega˚rd et al., 2013). In
a single sample we also detected HPV57, which can be found in
genital lesions among children as well as in common skin warts
(de Villiers et al., 2004). Possible reasons why the known HPV
types in these samples had not been detected in the initial general
primer PCR include the presence of viral variants with genomic
alterations in the sequences targeted by primers and probes, or
excessively low viral loads.
Beta- and Gammapapillomaviruses have been reported among
condylomas and in other genital lesions by sensitive PCR methods
(Chen et al., 2007; Ekstrom et al., 2010; Sturega˚rd et al., 2013). We
found the cutaneous Betapapillomaviruses HPV5, 105, 124, and
the Gammapapillomaviruses HPV50, 130, 150, and isolate KC7,
but at a low number of sequence reads. To the best of our
knowledge, these types have not previously been detected in
condylomas. The Beta- and Gammapapillomaviruses detected in
our study have so far only been associated with cutaneous lesions
and healthy skin. For example, HPV5 is associated with benign
and malignant lesions of the cutaneous disease epidermodyspla-
sia verruciformis (EV) (Zachow et al., 1987) and is common in
healthy skin of healthy individuals (Antonsson et al., 2003a).
HPV105 has been found in cutaneous squamous cell carcinoma
(SCC) and basal cell carcinoma (BCC) (de Villiers and Gunst, 2009).
HPV124 was found in an oral sample (Bottalico et al., 2011) and a
subgenomic part of HPV124 (FA23 sequence) was found in skin
swabs of a renal transplant recipient and a healthy volunteer
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found in an actinic keratosis of an EV-patient (Favre et al., 1989), but
has also been found on healthy skin of non-immunocompromised
individuals (Antonsson et al., 2003a). HPV130 was isolated from a
verrucous acanthoma of an immunosuppressed patient (Kohler
et al., 2011). A subgenomic part of HPV130 (FA147 sequence) was
found in an actinic keratosis (Forslund, 2007). HPV150 was isolated
from an eyebrow sample (Kocjan et al., 2005) and the KC7-isolate
from normal skin (Li et al., 2012).
In the present study, the condylomas were not tape-stripped
prior to collection of the swab samples (Forslund et al., 2004) and
it is possible that the Beta- and Gammapapillomaviruses detected
may have been derived from adjacent healthy genital skin. Beta-
and Gammapapillomavirus are frequently detected on healthy
skin (Antonsson et al., 2000; Forslund et al., 2004; Foulongne
et al., 2012). On the other hand, contamination from healthy skin
was not supported by the fact that we did not ﬁnd any sequences
of Merkel cell polyomavirus that is common on healthy skin
(Foulongne et al., 2012). It is also possible that the Beta- and
Gammapapillomaviruses may have been present not as causes of
the condyloma, but as secondary invaders that replicate prefer-
entially in abnormal keratinocytes of condylomatous tissue.
We detected a large diversity of subgenomic fragments of novel
HPV-sequences (23 sequences/contigs, SE87, SE92-SE107, SE109,
SE110, SE113-SE114, and SE116) that belonged to the Gammapa-
pillomavirus, which is a growing genus with 61 different comple-
tely sequenced HPV types/isolates (including FA69 and SE87
presented in this study) (Bernard et al., 2010; Bottalico et al.,
2011; Chouhy et al., 2010; Foulongne et al., 2012; Kohler et al.,
2011; Kovanda et al., 2011; Li et al., 2012) and 119 different
subgenomic sequences detected using the general primer PCR FAP
(FA-types) (Forslund, 2007) and/or with sequencing (SE-fragments)
(Ekstrom et al., 2011). The large number of novel subgenomic
fragments found suggests that the knowledge of the Gammapa-
pillomavirus genus is likely to expand with continued studies.
The complete genomes of Gammapapillomaviruses FA69 and
SE87 were compiled from a single swab sample, but have not
been given HPV numbers as they have not been cloned and
deposited with the international HPV reference center. The SE87
was most closely related to the HPV isolate 915F 06 005 FS1, that
was originally detected from healthy forehead skin by metage-
nomic sequencing (Foulongne et al., 2012). An FA69 sub-fragment
was also originally found in a swab sample of healthy forehead
skin (Antonsson et al., 2003b).
The general primer FAP-PCR has detected about 130 putative
HPV types (FA-isolates) as subgenomic L1-amplicons from skin
samples (Forslund, 2007). In the current study, only one of the
sequences was identical to an FA sequence (FA69).The novel
subgenomic sequences detected in the present study were from
various different parts of the HPV genome (mostly outside of the
FAP amplimer), and the possibility exists that some of them may
correspond to some of the previously reported FA-sequences.
We found that 40% of the pools and 33% of the individually
sequenced samples were negative for viral DNA. The DNA content of
these samples was adequate, as determined by betaglobin PCRs of
each sample (data not shown). The reason for the absence of viral
DNA in these samples is unknown but might be due to misclassi-
ﬁcation of clinical diagnosis of condyloma, or because these con-
dylomas were truly negative for virus, or because the viral copy
number was below the detection limit of the sequencing.
In summary, metagenomic sequencing of seemingly ‘‘HPV-nega-
tive’’ condylomas found that a substantial proportion of these
did contain HPV DNA. Sequencing of seemingly HPV-negative
samples from diseases known to be HPV-associated appears to be a
useful approach for expanding our knowledge of the diversity of
HPV types.Material and methods
Patients
Forty condyloma swab samples from two women, mean age
24.5 (22–27); two men, mean age 22.5 (21–24) from Denmark
(pool 1), and 19 women, mean age 31 (17–63); 17 men, mean age
31 (23–54) from Malmo¨, Sweden, (pool 2–10) were analyzed by
454 sequencing. The swab samples were collected with a pre-
wetted (0.9% NaCl) cotton-tipped swab rolled over the condyloma
and stored in 1 mL saline. The samples were centrifuged (5 min,
3500G) and 500 mL of the supernatant was left for pellet re-
suspension. Two-hundred mL was used for DNA extraction with
MagNA Pure LC using the Total Nucleic Acid Kit (Roche), and the
DNA was eluted in 100 mL elution buffer.
All patients provided informed consent and the ethical review
board of Lund, Sweden approved the study.
Sample preparation
Sample adequacy was assayed using beta-globin PCR, visua-
lized by gel electrophoresis in 11 cases and by qPCR in 29 cases
(Sturega˚rd et al., 2013).
To obtain the amount of DNA needed for sequencing (500 ng)
the samples were subjected to whole genome ampliﬁcation
(WGA) using GenomiPhi High Yield (GE Health Care, Buckin-
ghamshire, United Kingdom). For the pools, 3 mL of each of the
four samples was mixed before ampliﬁcation. The manufacturers
protocol was followed, with some modiﬁcations. In brief, 5 mL of
sample was mixed with 1 mL 10 BSA (New England Biolabs) and
22.5 mL of sample buffer. The mix was incubated at 95 1C at 3 min
and then cooled on ice. For the ampliﬁcation reaction, 22.5 mL
reaction buffer was mixed with 2.5 mL enzyme mix and added to
the sample and sample buffer. The samples were then incubated
at 30 1C for seven hours and subsequently inactivated at 65 1C for
10 min. The samples were diluted 1:2 in TE-buffer (0.1 mM EDTA)
to dissolve the sequencing products.
The pools and the single samples were sequenced with the 454
technology on a GS Junior platform (Roche). Multiplex identiﬁers
(MIDs), included in the 454 adaptors, were used to assign the
obtained sequences to the originating sample or pool.
Analysis of obtained sequences
The sequences were trimmed for tails containing ambiguous
bases (bases with a Phred quality score less than 20, equivalent to
a base calling accuracy of 99%, 1 error in 100 bases (Ewing and
Green, 1998)). Reads with a length of more than 80 bp and with
less than 20% of ambiguous bases were screened for similarity to
human and bacterial DNA using NCBI MEGABLAST (Altschul et al.,
1997). Reads with at least 95% identity over 75% of their length to
human or bacterial DNA were removed. The remaining sequences
were processed for assembly of contiguous sequences (contigs)
using a WGS CELERA assembler (Miller et al., 2008).
All assembled contigs and singletons were then compared
against GenBank using the NCBI BLASTn (Altschul et al., 1997)
(reward for nucleotide match¼1; penalty of nucleotide mis-
match¼1; cost to open a gap¼0; cost to extend a gap¼2;
e-valuere4).
All sequences that gave signiﬁcant hits for papillomaviruses
were retrieved as singletons from the pre-assembly database and
checked for possible chimeras. Chimeras are reads that are
composed of sequences from two or more different origins, or
that have parts that are inverted. Sequences that had different
degrees of similarity over their length to the most closely related
sequence in GenBank were considered as possible chimeras, i.e.,
H. Johansson et al. / Virology 440 (2013) 1–76possibly containing sequences originating from different viruses.
The sequence that aligned to its most closely related sequence in
GenBank was divided into three equal segments. If at least one of
the segments had less than 90% similarity, and at least one had
more than 90% similarity, and if the difference between these
segments in terms of similarity to corresponding overlapping
parts was more than 5% (for example if segment 1 was 88%
similar and segment 2 was 94% similar) the sequence was
considered as a ‘‘possible chimera’’ and excluded from further
analysis. If there was less than 5% difference between the above
described segments in terms of similarity to corresponding over-
lapping parts (for example segment 1 was 89% similar and
segment 2 was 93% similar) the sequence was additionally
checked whether the sequence had an approximately equal
frequency of nucleotide matches to its top blast hit across the
overlapping part. If part of the selected sequence (4¼30 bp) did
not match with the top hit in the GenBank search, this part was
cut and re-checked with the NCBI nucleotide database. If the top
blast hit of these sequences was different from the top blast hit of
the other part and/or the difference between their percent ide-
ntities was 4¼10% the sequence was also considered as a
‘‘possible chimera’’ and excluded from further analysis. Papill-
omavirus-related singletons which were not classiﬁed as putative
chimeras were assembled using a WGS CELERA assembler and
then compared against GenBank using the NCBI BLASTn (Altschul
et al., 1997) (reward for nucleotide match¼1; penalty of nucleo-
tide mismatch¼1; cost to open a gap¼0; cost to extend a gap¼2;
e-valuere4).
CodonCode Aligner
A CodonCode Aligner (version 4.0.3, CodonCode Corporation)
was used for further assembly of sequences into contigs using the
default settings. The CodonCode Aligner was also used to manu-
ally detect chimeras.
Compilation of complete genomes of SE87 and FA69
The contigs representing the complete genomes of SE87 and
FA69 were assembled using the WGS CELERA assembler. Initially,
the ORFs were incomplete in three and four positions of the
contigs for SE87 and FA69, respectively. The pre-terminal stop
codons and nucleotides leading to frameshift were identiﬁed by
BioEdit v. 7.1.3.0 and software for analysis of translation of
reading frames (http://bio.lundberg.gu.se/edu/translat.html). In
order to explore whether these pre-terminal stop codons and
frameshifts may have been due to sequencing errors, PCR pro-
ducts were generated from the original sample, the amplimers
were sequenced, and the amplimer sequences were then used to
edit the ﬁnal sequence.Acknowledgements
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